molecular-guided treatment of b-cell lymphomas
Published 6 years ago • 247 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:42
precision medicine for b-cell lymphomas
-
1:38
molecular subtypes in diffuse large b-cell lymphoma
-
3:40
master class in transplantation and hematology: highlights
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
6:43
phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
-
6:23
molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
7:48
glofitamab, a cd20/cd3 bispecific antibody, in the treatment of r/r dlbcl
-
1:47
shared treatment decision-making
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
5:39
acalabrutinib monotherapy in mature b-cell malignancies
-
0:42
targeted therapies for dlbcl treatment
-
3:24
molecular profiling to determine treatment for all and aml